- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6869 - Methods for sequencing
Patent holdings for IPC class C12Q 1/6869
Total number of patents in this class: 7712
10-year publication summary
219
|
269
|
571
|
791
|
882
|
995
|
906
|
998
|
988
|
570
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Illumina, Inc. | 3345 |
556 |
Roche Sequencing Solutions, Inc. | 647 |
241 |
Illumina Cambridge Limited | 678 |
206 |
Life Technologies Corporation | 3295 |
171 |
Oxford NanoPore Technologies plc | 320 |
164 |
Pacific Biosciences of California, Inc. | 760 |
153 |
Guardant Health, Inc. | 417 |
128 |
The Regents of the University of California | 19898 |
120 |
President and Fellows of Harvard College | 5975 |
113 |
Natera, Inc. | 320 |
108 |
10X Genomics, Inc. | 1204 |
98 |
The Board of Trustees of the Leland Stanford Junior University | 6402 |
87 |
Quantum-Si Incorporated | 442 |
86 |
Singular Genomics Systems, Inc. | 284 |
70 |
Ultima Genomics, Inc. | 207 |
68 |
BGI Shenzhen | 522 |
65 |
Element Biosciences, Inc. | 190 |
65 |
F. Hoffmann-La Roche AG | 7930 |
64 |
Oxford NanoPore Technologies Limited | 272 |
64 |
Prognosys Biosciences, Inc. | 104 |
62 |
Other owners | 5023 |